Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
Civic Repair Delays Spark Frustration Across Indian Cities
Northeast Development Summit 2025 Focuses on Regional Integration and Growth
Reuters says Nvidia’s Huang to meet Trump before China trip, markets watching
Government Revamps School Meals to Boost Student Health and Nutrition
WNBA stars aim for All Star redemption
